<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Epidemiology and Population Health</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5F551E3E-DFD9-48EC-A31B-080D7C19BE5F"><gtr:id>5F551E3E-DFD9-48EC-A31B-080D7C19BE5F</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Whittaker</gtr:surname><gtr:orcidId>0000-0002-3529-2379</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F5D73434-599C-4156-B196-5603C8584E6D"><gtr:id>F5D73434-599C-4156-B196-5603C8584E6D</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F49B63C6-70FC-4834-B7B6-58593A167F7B"><gtr:id>F49B63C6-70FC-4834-B7B6-58593A167F7B</gtr:id><gtr:firstName>Liam</gtr:firstName><gtr:surname>Smeeth</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600621"><gtr:id>3595B7DC-0C24-408B-8F20-32721EF50025</gtr:id><gtr:title>Statistical methods for analysis of adverse effects associated with drugs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600621</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>119123</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>CHMP Pharmacovigilance Working Party of EU</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>33F453BF-DE75-4FF5-90FF-98FF46DEDD44</gtr:id><gtr:impact>Bayesian methods encouraged in searching for signals of ADR</gtr:impact><gtr:outcomeId>pAkYWFakLn4</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C5DE3BB0-986F-44BF-B358-89C8E31EAE35</gtr:id><gtr:title>Why a Bayesian approach to safety analysis in pharmacovigilance is important.</gtr:title><gtr:parentPublicationTitle>Pharmaceutical statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2d2387ab6d4015b64a678f555042d8f"><gtr:id>a2d2387ab6d4015b64a678f555042d8f</gtr:id><gtr:otherNames>Prieto-Merino D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1539-1604</gtr:issn><gtr:outcomeId>pm_16074_24_22140036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F93183B-724C-4A12-B63A-563820DEDDA2</gtr:id><gtr:title>Using Different Types of Priors in a Bayesian Hierarchical Model for the Analysis of Drug Adverse Events</gtr:title><gtr:parentPublicationTitle>PHARMACOEPIDEMIOLOGY AND DRUG SAFETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f7930a26422a3b83338502513a94d65"><gtr:id>8f7930a26422a3b83338502513a94d65</gtr:id><gtr:otherNames>Prieto-Merino David</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8569</gtr:issn><gtr:outcomeId>BoiNSZq7xsc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9105AC21-5248-472B-BAA8-997DFD203E0D</gtr:id><gtr:title>Novel statistical tools for monitoring the safety of marketed drugs.</gtr:title><gtr:parentPublicationTitle>Clinical pharmacology and therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07b017a7c629d7b6d9b9439d6310e5e9"><gtr:id>07b017a7c629d7b6d9b9439d6310e5e9</gtr:id><gtr:otherNames>Almenoff JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-9236</gtr:issn><gtr:outcomeId>sb7AwYG2dkc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>500CE207-C9EC-463E-AFB2-2A4C51A5E753</gtr:id><gtr:title>Pharmacoepidemiology.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e0d4e7f8ede732817caf54d3c97d372"><gtr:id>9e0d4e7f8ede732817caf54d3c97d372</gtr:id><gtr:otherNames>Evans SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>pm_16074_24_22360737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>350BE4F2-65F1-4694-8879-E36400F09BE7</gtr:id><gtr:title>Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.</gtr:title><gtr:parentPublicationTitle>Drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d50f63b591d476fb1dc929dcfbe4e22f"><gtr:id>d50f63b591d476fb1dc929dcfbe4e22f</gtr:id><gtr:otherNames>Crooks CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0114-5916</gtr:issn><gtr:outcomeId>pm_16074_24_22136183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFFA54CB-DBF5-43C6-901D-C3E14C42D0F3</gtr:id><gtr:title>Effects of Different Groupings of Drug Adverse Events in the Detection of Signals Using Bayesian Analyses</gtr:title><gtr:parentPublicationTitle>PHARMACOEPIDEMIOLOGY AND DRUG SAFETY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f7930a26422a3b83338502513a94d65"><gtr:id>8f7930a26422a3b83338502513a94d65</gtr:id><gtr:otherNames>Prieto-Merino David</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8569</gtr:issn><gtr:outcomeId>m1vK6SngYwD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC106ADA-BF7C-46DB-B558-7AE06196B0BE</gtr:id><gtr:title>Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods.</gtr:title><gtr:parentPublicationTitle>Medical care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a20c5cb6f8533ec7326ada2033fa6636"><gtr:id>a20c5cb6f8533ec7326ada2033fa6636</gtr:id><gtr:otherNames>Schuemie MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0025-7079</gtr:issn><gtr:outcomeId>pm_16074_24_22929992</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600621</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>